Want to see YCBD full AI Analyst Report?
YCBD Stock Chart & Stats
$0.54
-$0.04(-6.65%)
At close: 4:00 PM EDT
$0.54
-$0.04(-6.65%)
Day’s Range― - ―
52-Week Range$0.47 - $2.56
Previous CloseN/A
Volume341.40K
Average Volume (3M)7.54M
Market Cap
$5.93M
Enterprise Value$7.24
Total Cash (Recent Filing)$2.12B
Total Debt (Recent Filing)$350.95M
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Dec 18, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding10,497,919
10 Day Avg. Volume860,286
30 Day Avg. Volume7,543,844
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.67
Price to Sales (P/S)0.25
P/FCF Ratio-2.97
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.19
Revenue Forecast (FY)$22.15M
Bulls Say, Bears Say
Bulls Say
AcquisitionAnalyst views the acquisition of Bluebird Botanicals as strategic because it adds a premium hemp-derived CBD brand with an established e-commerce customer base and creates cross-selling opportunities across existing product lines.
Operating StabilityAnalyst sees operating stabilization after a company transformation that lowered fixed costs, reduced balance-sheet risk, and refocused the product portfolio toward higher-demand, higher-margin items.
Retail DistributionAnalyst notes expanded distribution and recent product innovation for the Herbal Oasis THC-infused seltzer portfolio should broaden retail reach and support top-line growth.
Bears Say
Legislative RiskAnalyst warns that H.R. 5371 could materially disrupt sales of certain THC-containing SKUs, including Herbal Oasis THC seltzers, creating significant uncertainty for revenue from those products.
LiquidityAnalyst flags a constrained cash position, noting limited liquidity could pressure operations even with access to a committed credit line that extends the financial runway temporarily.
cbdMD News
YCBD FAQ
What was cbdMD’s price range in the past 12 months?
cbdMD lowest stock price was $0.47 and its highest was $2.56 in the past 12 months.
What is cbdMD’s market cap?
cbdMD’s market cap is $5.93M.
When is cbdMD’s upcoming earnings report date?
cbdMD’s upcoming earnings report date is Dec 18, 2026 which is in 124 days.
How were cbdMD’s earnings last quarter?
cbdMD released its earnings results on Aug 13, 2026. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.08.
Is cbdMD overvalued?
According to Wall Street analysts cbdMD’s price is currently Overvalued.
Does cbdMD pay dividends?
cbdMD does not currently pay dividends.
What is cbdMD’s EPS estimate?
cbdMD’s EPS estimate is -0.03.
How many shares outstanding does cbdMD have?
cbdMD has 10,497,919 shares outstanding.
What happened to cbdMD’s price movement after its last earnings report?
cbdMD reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -12.389%.
Which hedge fund is a major shareholder of cbdMD?
Currently, no hedge funds are holding shares in YCBD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
cbdMD
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
YCBD Company Deck
YCBD Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented balanced progress: clear top-line growth drivers (20% quarterly revenue growth, 61% wholesale growth, Oasis momentum, >$0.5M from Bluebird) and operational actions (cost reductions, product launches) that position the company to navigate near-term uncertainty. However, margin compression (gross margin down ~570 bps YoY in the quarter), higher operating losses and working capital build, inventory reserves, state-level restrictions, and material regulatory uncertainty are significant headwinds. Management emphasized deliberate investments and a path to improved adjusted EBITDA and lower cash burn, but tangible risks remain until regulatory clarity and cost savings are fully realized.View all YCBD earnings summariesTechnical Analysis
Ownership Overview
15.05% Insiders
0.50% Mutual Funds
4.62% Other Institutional Investors
78.70% Public Companies and
Individual Investors